KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cigna (CI) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Cigna (CI) over the last 8 years, with Q3 2025 value amounting to $38.0 million.

  • Cigna's Other Operating Expenses rose 14367.82% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.0 million, marking a year-over-year increase of 11319.44%. This contributed to the annual value of $24.0 million for FY2024, which is 10160.11% up from last year.
  • As of Q3 2025, Cigna's Other Operating Expenses stood at $38.0 million, which was up 14367.82% from $41.0 million recorded in Q1 2025.
  • Over the past 5 years, Cigna's Other Operating Expenses peaked at $39.8 billion during Q2 2022, and registered a low of -$1.5 billion during Q4 2023.
  • In the last 5 years, Cigna's Other Operating Expenses had a median value of $41.0 million in 2025 and averaged $11.7 billion.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first crashed by 192465.75% in 2023, then skyrocketed by 31578.95% in 2025.
  • Over the past 5 years, Cigna's Other Operating Expenses (Quarter) stood at $38.0 billion in 2021, then tumbled by 100.19% to -$73.0 million in 2022, then plummeted by 1924.66% to -$1.5 billion in 2023, then soared by 108.8% to $130.0 million in 2024, then tumbled by 70.77% to $38.0 million in 2025.
  • Its Other Operating Expenses stands at $38.0 million for Q3 2025, versus $41.0 million for Q1 2025 and $130.0 million for Q4 2024.